Pairing next generation software, analytic, and generative AI with next generation tailor-made therapeutics
Regenerative Medicine is using the body's engineered and modified cells to repair, replace, regenerate, and rejuvenate tissues and organs. The areas of most active research are cell and gene therapy and stem cells.
Cellular Immunotherapy
Gene Editing
Stem Cells
Tissue Engineering & BioMaterials
Direct T-cell re-programming
Exosome Therapy
Cellular Scaffolds and Matrices
3D Bioprinting
Ongoing Global Clinical Trials in Cell and Gene Therapy
1345
CANCER
174
NEUROLOGICAL
172
DIABETES
111
CARDIOVASCULAR
RARE DISEASES
77
STROKE
Fewer than 50% of clinical supply leaders have confidence in their ability to supply cell and gene therapy trials.
Login or Register to learn more.
We deliver decades of academic promise to clinical reality, just-in-time.
Drug development, iterative formulations, manufacturing, and clinical trials are inextricably linked, with patient inclusion at every step.
MDVerse is the crucial integration of the drug creator, pharma, CDMO, academia, clinical site, and materials ecosystem.
@dawndaniel - MD
MDVerse enables the revolution in advanced therapies by leveraging our next-generation software, analytics, and AI/ML with industry best practices to ensure precision therapeutics are delivered within the entire ATMP ecosystem
MD, FAASM, Co-Founder, CEO
Co-Founder, CTO
MD, MSc, DSc, Board Member/Consultant
Board Member
Send us a message
First Name
Last Name
Email Address
Phone Number
Organization/Company Name
Please describe your interest in MDVerse